Sepsis with Cancer is Marked by a Dysregulated Myeloid Cell Compartment: A Pilot Study
Wenqian Qi,1 Junyan Han,2,3 Yu Cao,2,3 Hao Yu,2,3 Jingjing Hao,1 Ningning Yin,1 Xuefeng Zang,4 Lei Zhao,5 Wei Chen,4 Chen Chen,2,3 Hui Zeng,2,3 Jingyuan Liu,1 Ang Li1 1Intensive Care Unit, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, People’s Republic of China; 2Biomedical In...
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-07-01
|
| Series: | Journal of Inflammation Research |
| Subjects: | |
| Online Access: | https://www.dovepress.com/sepsis-with-cancer-is-marked-by-a-dysregulated-myeloid-cell-compartmen-peer-reviewed-fulltext-article-JIR |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849422034431377408 |
|---|---|
| author | Qi W Han J Cao Y Yu H Hao J Yin N Zang X Zhao L Chen W Chen C Zeng H Liu J Li A |
| author_facet | Qi W Han J Cao Y Yu H Hao J Yin N Zang X Zhao L Chen W Chen C Zeng H Liu J Li A |
| author_sort | Qi W |
| collection | DOAJ |
| description | Wenqian Qi,1 Junyan Han,2,3 Yu Cao,2,3 Hao Yu,2,3 Jingjing Hao,1 Ningning Yin,1 Xuefeng Zang,4 Lei Zhao,5 Wei Chen,4 Chen Chen,2,3 Hui Zeng,2,3 Jingyuan Liu,1 Ang Li1 1Intensive Care Unit, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, People’s Republic of China; 2Biomedical Innovation Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, People’s Republic of China; 3Beijing Key Laboratory for Therapeutic Cancer Vaccines, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, People’s Republic of China; 4Department of Intensive Care Unit, Beijing Shijitan Hospital Affiliated to Capital Medical University, Beijing, 100038, People’s Republic of China; 5Department of Critical Care Medicine, Emergency and Critical Care Medical Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, People’s Republic of ChinaCorrespondence: Ang Li, Intensive Care Unit, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, People’s Republic of China, Email liang@ccmu.edu.cnBackground: Sepsis accounts for a significant proportion of global deaths and has limited treatment options. Cancer patients are at a higher risk of sepsis and experience worse outcomes, highlighting the complex interplay between sepsis and cancer on immune cell function and clinical prognosis.Methods: Between July and December 2023, we prospectively enrolled 30 sepsis patients and 10 healthy controls, categorizing the patients into sepsis with non-cancer and sepsis with cancer based on established clinical diagnostics. Multi-color flow cytometry was used to monitor changes in the expression of surface molecules of monocyte and neutrophil subsets, phagocytic activity and cytokine-producing capacity.Results: Compared with sepsis with non-cancer, the sepsis with cancer group demonstrated elevated 28-day mortality rates, increased CD177+ activated band neutrophil and HLA-DRlowCCR2low classical monocyte, and attenuated phagocytic activity of immature neutrophil and monocyte. Further, HLA-DRlowCCR2low classical monocytes and CD177+ myelocytes may serve as immunological predictors of adverse outcomes in sepsis. The HLA-DRlowCCR2low classical monocyte and CD177+ myelocytes exhibit significant correlations with internal environment and coagulation markers.Conclusion: In septic patients, particularly those patients with cancer, attenuated phagocytic activity of immature neutrophil (myelocytes, metamyelocytes, band neutrophils) and monocyte, and HLA-DRlowCCR2low classical monocyte and CD177+ myelocytes may serve as immunological predictors of poor prognosis.Keywords: sepsis, monocyte, neutrophil, cancer |
| format | Article |
| id | doaj-art-2b03e91a37e94a53b15326dfb84faf33 |
| institution | Kabale University |
| issn | 1178-7031 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Journal of Inflammation Research |
| spelling | doaj-art-2b03e91a37e94a53b15326dfb84faf332025-08-20T03:31:16ZengDove Medical PressJournal of Inflammation Research1178-70312025-07-01Volume 18Issue 186438656104410Sepsis with Cancer is Marked by a Dysregulated Myeloid Cell Compartment: A Pilot StudyQi W0Han J1Cao YYu H2Hao J3Yin N4Zang XZhao L5Chen W6Chen C7Zeng H8Liu J9Li A10ICUBiomedical Innovation Centerbiomedical innovation centerDepartment of Critical Care MedicineDepartment of Critical Care MedicineDepartment of Critical Care MedicineDepartment of Critical Care MedicineBiomedical Innovation CenterBiomedical Innovation CenterDepartment of Critical Care MedicineDepartment of Critical Care MedicineWenqian Qi,1 Junyan Han,2,3 Yu Cao,2,3 Hao Yu,2,3 Jingjing Hao,1 Ningning Yin,1 Xuefeng Zang,4 Lei Zhao,5 Wei Chen,4 Chen Chen,2,3 Hui Zeng,2,3 Jingyuan Liu,1 Ang Li1 1Intensive Care Unit, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, People’s Republic of China; 2Biomedical Innovation Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, People’s Republic of China; 3Beijing Key Laboratory for Therapeutic Cancer Vaccines, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, People’s Republic of China; 4Department of Intensive Care Unit, Beijing Shijitan Hospital Affiliated to Capital Medical University, Beijing, 100038, People’s Republic of China; 5Department of Critical Care Medicine, Emergency and Critical Care Medical Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, People’s Republic of ChinaCorrespondence: Ang Li, Intensive Care Unit, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, People’s Republic of China, Email liang@ccmu.edu.cnBackground: Sepsis accounts for a significant proportion of global deaths and has limited treatment options. Cancer patients are at a higher risk of sepsis and experience worse outcomes, highlighting the complex interplay between sepsis and cancer on immune cell function and clinical prognosis.Methods: Between July and December 2023, we prospectively enrolled 30 sepsis patients and 10 healthy controls, categorizing the patients into sepsis with non-cancer and sepsis with cancer based on established clinical diagnostics. Multi-color flow cytometry was used to monitor changes in the expression of surface molecules of monocyte and neutrophil subsets, phagocytic activity and cytokine-producing capacity.Results: Compared with sepsis with non-cancer, the sepsis with cancer group demonstrated elevated 28-day mortality rates, increased CD177+ activated band neutrophil and HLA-DRlowCCR2low classical monocyte, and attenuated phagocytic activity of immature neutrophil and monocyte. Further, HLA-DRlowCCR2low classical monocytes and CD177+ myelocytes may serve as immunological predictors of adverse outcomes in sepsis. The HLA-DRlowCCR2low classical monocyte and CD177+ myelocytes exhibit significant correlations with internal environment and coagulation markers.Conclusion: In septic patients, particularly those patients with cancer, attenuated phagocytic activity of immature neutrophil (myelocytes, metamyelocytes, band neutrophils) and monocyte, and HLA-DRlowCCR2low classical monocyte and CD177+ myelocytes may serve as immunological predictors of poor prognosis.Keywords: sepsis, monocyte, neutrophil, cancerhttps://www.dovepress.com/sepsis-with-cancer-is-marked-by-a-dysregulated-myeloid-cell-compartmen-peer-reviewed-fulltext-article-JIRSepsisMonocyteNeutrophilCancer |
| spellingShingle | Qi W Han J Cao Y Yu H Hao J Yin N Zang X Zhao L Chen W Chen C Zeng H Liu J Li A Sepsis with Cancer is Marked by a Dysregulated Myeloid Cell Compartment: A Pilot Study Journal of Inflammation Research Sepsis Monocyte Neutrophil Cancer |
| title | Sepsis with Cancer is Marked by a Dysregulated Myeloid Cell Compartment: A Pilot Study |
| title_full | Sepsis with Cancer is Marked by a Dysregulated Myeloid Cell Compartment: A Pilot Study |
| title_fullStr | Sepsis with Cancer is Marked by a Dysregulated Myeloid Cell Compartment: A Pilot Study |
| title_full_unstemmed | Sepsis with Cancer is Marked by a Dysregulated Myeloid Cell Compartment: A Pilot Study |
| title_short | Sepsis with Cancer is Marked by a Dysregulated Myeloid Cell Compartment: A Pilot Study |
| title_sort | sepsis with cancer is marked by a dysregulated myeloid cell compartment a pilot study |
| topic | Sepsis Monocyte Neutrophil Cancer |
| url | https://www.dovepress.com/sepsis-with-cancer-is-marked-by-a-dysregulated-myeloid-cell-compartmen-peer-reviewed-fulltext-article-JIR |
| work_keys_str_mv | AT qiw sepsiswithcancerismarkedbyadysregulatedmyeloidcellcompartmentapilotstudy AT hanj sepsiswithcancerismarkedbyadysregulatedmyeloidcellcompartmentapilotstudy AT caoy sepsiswithcancerismarkedbyadysregulatedmyeloidcellcompartmentapilotstudy AT yuh sepsiswithcancerismarkedbyadysregulatedmyeloidcellcompartmentapilotstudy AT haoj sepsiswithcancerismarkedbyadysregulatedmyeloidcellcompartmentapilotstudy AT yinn sepsiswithcancerismarkedbyadysregulatedmyeloidcellcompartmentapilotstudy AT zangx sepsiswithcancerismarkedbyadysregulatedmyeloidcellcompartmentapilotstudy AT zhaol sepsiswithcancerismarkedbyadysregulatedmyeloidcellcompartmentapilotstudy AT chenw sepsiswithcancerismarkedbyadysregulatedmyeloidcellcompartmentapilotstudy AT chenc sepsiswithcancerismarkedbyadysregulatedmyeloidcellcompartmentapilotstudy AT zengh sepsiswithcancerismarkedbyadysregulatedmyeloidcellcompartmentapilotstudy AT liuj sepsiswithcancerismarkedbyadysregulatedmyeloidcellcompartmentapilotstudy AT lia sepsiswithcancerismarkedbyadysregulatedmyeloidcellcompartmentapilotstudy |